About Kcat
Kcat is a Healthcare company based in Bengaluru (India) founded in 2018 by Lalitha Roopa, Gladstone Sigamani, and Pravin Kumar. Solutions and services for protein optimization and engineering are provided. The company has 38 employees. Its chief executive, as recorded, is Gladstone Sigamani. Its Indian entity Kcat Enzymatic Private Limited reported revenue of ₹4.67 Cr. Kcat offers products and services including Insilico Protein Engineering, Synthetic Biology Services, and Scale-Up Framework. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
Kcat was founded in 2018 in Bengaluru, India, within the biotechnology sector. Solutions and services focused on protein optimization and engineering are delivered to computational chemists and biologists. Proprietary patented technology is employed to derive transition and intermediate states in bio-catalytic reactions through molecular dynamics and quantum mechanics. Additional offerings include tools for mutagenesis, protein purification, enzyme activity determination, and kinetic resolution in biochemical studies.
- Headquarters Bengaluru, India
- Employees 38
- Founders Lalitha Roopa, Gladstone Sigamani, Pravin Kumar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kcat.co.in
- Social LinkedIn X Facebook Instagram
- Legal Name Kcat Enzymatic Private Limited
- Date of Incorporation 26 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹4.67 Cr
FY 2025 · +228% YoY
- Net Profit₹71.4 Lakh
FY 2025 · 15% margin
- EBITDA₹2.79 Cr
FY 2025 · 60% margin
- InvestorsStartup Karnataka
& 1 more
- Employee Count38
Associated legal entities of Kcat
Kcat operates through Kcat Enzymatic Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kcat Enzymatic Private Limited CIN U73100KA2018PTC116908 | Active | 26 Sep 2018 | Bangalore, Karnataka | ₹4.7 Cr | 38 | 4 | View details |
Products & Services of Kcat
Kcat offers a comprehensive portfolio of products and services, including Insilico Protein Engineering, Synthetic Biology Services, and Scale-Up Framework.
Advanced simulation for identifying enzyme functional hotspots and substitutions
Techniques to produce chemical building blocks from renewable resources
Framework for enzyme development including cloning and fermentation
Funding Insights of Kcat
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Kcat with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | Seed | – | Ideaspring Capital | – | |
| Jun 2019 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Kcat
Kcat has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Startup Karnataka and Ideaspring Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are provided to technology startups by Ideaspring Capital. | ideaspringcap.com | Bengaluru, India | ||
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India |
Investor details for Kcat
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Kcat Enzymatic Private Limited (Kcat)
Kcat Enzymatic Private Limited is the primary company behind Kcat. The board of Kcat Enzymatic Private Limited currently have 4 directors; the longest-serving is Pravin Kumar Ramalingam, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pravin Kumar Ramalingam DIN 02117762 | Director | 26 Sep 2018 | 8 yrs 1 mo | Kcat Enzymatic Private Limited |
| Immanuel Gunaseelan Gladstone Sigamani DIN 08240060 | Director | 26 Sep 2018 | 8 yrs 1 mo | Kcat Enzymatic Private Limited |
| Roopal Pillai DIN 08240061 | Director | 26 Sep 2018 | 8 yrs 1 mo | Kcat Enzymatic Private Limited |
| Naganand Doraswamy DIN 01305436 | Nominee Director | 14 Oct 2024 | 2 yrs | Kcat Enzymatic Private Limited |
People of Kcat
3 people are tracked at Kcat (3 in leadership); the tracked headcount is 38.
| Name | Role | Group |
|---|---|---|
Lalitha Roopa | Co-Founder | Leadership |
| Co-Founder & CEO | Leadership | |
| Co-Founder & CSO | Leadership |
Complete people profiles for Kcat
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Kcat
Figures of Kcat Enzymatic Private Limited, the primary company behind Kcat, for FY 2025. Revenue was ₹4.67 Cr (+228% year on year). Net profit was ₹71.4 Lakh (15% margin). EBITDA was ₹2.79 Cr (60% margin). Revenue has grown at a compounded annual rate of +56% over three years and +74% over five years.
- ₹4.67 CrRevenue · FY 2025 · +228% YoY
- ₹71.4 LakhNet profit · 15% margin
- ₹2.79 CrEBITDA · 60% margin
- ₹1.2 LakhPaid-up capital
- 38Employees (provident fund records)
- +56%Revenue CAGR, 3 years
- +74%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kcat Enzymatic Private Limited are on its company page.
Detailed financial statements for Kcat
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Kcat
3 dated milestones of Kcat across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Kcat is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kcat
Kcat was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Kcat is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Gladstone Sigamani is the CEO of Kcat, as recorded in our data. They have also founded this company.
Kcat has 38 employees.
The primary company behind Kcat, Kcat Enzymatic Private Limited, reported revenue of ₹4.67 Cr for FY 2025, up 228% year on year.
Kcat was founded in 2018 in Bengaluru, India, within the biotechnology sector. Solutions and services focused on protein optimization and engineering are delivered to computational chemists and biologists. Proprietary patented technology is employed to derive transition and intermediate states in bio-catalytic reactions through molecular dynamics and quantum mechanics. Additional offerings include tools for mutagenesis, protein purification, enzyme activity determination, and kinetic resolution in biochemical studies.
Kcat offers Insilico Protein Engineering, Synthetic Biology Services, and Scale-Up Framework.
Kcat has 2 investors. Key investors include Startup Karnataka, and Ideaspring Capital.
Kcat operates through Kcat Enzymatic Private Limited.
The legal entities of Kcat currently have 4 directors, including Naganand Doraswamy, Pravin Kumar Ramalingam, Immanuel Gunaseelan Gladstone Sigamani and others.